Eris Lifesciences Ltd - 540596 - Board Meeting Intimation for Consideration And Approval Of The Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter Ended 31 December 2022.
Eris Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/01/2023 ,inter alia, to consider and approve unaudited financial results of the Company for the quarter ended 31 December 2022.10-01-2023